skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Any idea of when this stock will be trading again? Have you ever seen an auditing scandal with a happy ending? You would think this would be trading below $1 when trading eventually reopens. Also, could this company face litigation from shareholders who were obviously duped? Looks fishy with the American headquarters (ie why list in Canada when the American Market is much larger)
Read Answer Asked by Thomas on March 15, 2018
Q: This announcement just came down....I hold this stock at 3.90 a share. Is this a positive announcement? Should I continue to hold ? Your comments are appreciated. Rita
Wednesday, March 14, 2018, 9:00 AM ET

ZUG, Switzerland and VANCOUVER, March 14, 2018 /CNW/ - HIVE Blockchain Technologies Ltd. (TSX.V:HIVE) (OTC:HVBTF) (the "Company" or "HIVE") is pleased to announce that it has applied for listing of an aggregate of 48,830,150 common share purchase warrants (the "Warrants") on the TSX Venture Exchange ("TSXV") as a supplemental listing. The Warrants were issued pursuant to private placements of the Company that closed on November 14, 2017, December 18, 2017 and December 29, 2017.
Subject to TSXV approval, the Warrants will commence trading on the TSXV under the symbol "HIVE.WT" concurrently with the expiry of each applicable four month and a day hold period attached to such Warrants. 12,322,250 of the Warrants are expected to be listed on March 15, 2018, 15,873,100 of the Warrants on April 19, 2018 and the remaining 20,634,800 Warrants on April 30, 2018.
Each Warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of C$3.90 until November 14, 2019. The Warrants were issued pursuant to, and are governed by, a warrant indenture between the Company and Computershare Trust Company of Canada dated November 14, 2017, as supplemented by the first supplemental warrant indenture dated December 18, 2017.
About HIVE Blockchain Technologies Ltd.
Read Answer Asked by Rita on March 14, 2018
Q: Peter and His Winder Team
This 55 million dollar order has to be good news. Does it validate that there new products will probably be in demand? In the scheme of things what implications might this have for there future...keeping in mind they have been struggling for a long time!
Thank you for your great service!
Read Answer Asked by Ernest on March 14, 2018
Q: Hello,

I was wondering what your thoughts are on RHT given it's current price ( ~$2.22 as of today). Based on the most recent share count outstanding (81,871,000), this suggests an EV of about $180 MM for a company that is showing 6 month revenue of $1.1 MM. While I know that early stage companies are based on what the future holds, I also like to keep an eye on what EBITDA needs to be (in the future) to justify valuations. For instance, in the case of RHT, if one believes that within the next 12-24 months they can achieve EBITDA of ~ $12 MM, then this would suggest that today it is trading at a EV/EBITDA multiple of 15 based on future results. EBITDA of $12 MM in turn is achievable if they can hit ~ $20.5 MM in gross revenue with a 78% gross margin (as per most recent financials) and no increase in cash expenses of $4.0 MM annually, as 6 month financials suggest ~ $2.0 MM in cash expenses. In short, does your modelling of RHT suggest/indicate that this is a realistic expectation, and that within the 12-24 month time frame they can reach ~ $20 MM in gross revenue with no margin compression and no increase in cash G&A costs ?

Thanks!
Read Answer Asked by Mike on March 13, 2018
Q: Hello 5i team; Any new thoughts on PEO and BYL. I am getting a bit impatient with both of these as of late. I am down 14% on BYL and 5% on PEO since buying them. I know you think highly of PEO. Do you feel it is consolidating after the previous run up or is there material weakness building in some regard? I am looking for near term catalysts to get these 2 stocks moving. BYL from my take should have numerous new avenues of growth after its recent takeover stemming from the whole roster of products acquired and now being able to sell them to their "approved" customers, in which Advantech never could because it didn't have the rights (from what I have gathered from company statements). Anyways just looking for some guidance if I should just hold on and ride these 2 out or sell and move on....
Read Answer Asked by Shane on March 13, 2018
Q: In Nov IRO.v reported TTM EPS of $0.11USD for Q3 & it closed on Friday at $0.485. It appears to be extremely cheap with a P/E of roughly 3x. Fundamentals have been improving each quarter. They have some debt from the transformational acquisition of Papillon in 2016 but have been paying it down rapidly in 2017. With these key points above, I think it deserves some further consideration.

Another subscriber had asked about IRO in January & 5i said “At less than $10M market cap, we would completely avoid IRO.” Yes I agree, it’s a very illiquid microcap but that does not concern me because I’m not buying million of shares. I recently purchased a few thousand shares in my TFSA account. I thought it has potential to be a 4bagger this yr. Do you really think it should be avoid & why?
Read Answer Asked by David on March 12, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!